The author discusses the economic costs of preventable brain disorders like amygdala dysfunctions. Inefficient management of these conditions leads to high societal costs from related crimes and healthcare needs. Developing diagnostic systems could help detect issues earlier and reduce negative events. More research is also needed to understand these disorders and develop appropriate treatments to contain their effects and costs to society. The author argues these conditions should be considered diseases to allow preventive measures like restrictions applied to other medical issues.